The Middle East and North Africa (MENA) region is made up of 23 countries, each with a unique demographic, cultural, religious and socio-economic profile.
Civil society organizations in the region are still fragile, and not recognized as a priority by donors and the international community.
The poor functioning or lack of organization of civil society in this sub-region is the result of less capacity for intervention, social stigmatization, and the non-recognition of these organizations by governments.
This finding has serious, wide-ranging effects on the response to HIV/AIDS and TB in the different countries of the region.
In 2017, The Global Fund supported funding programs in 15 countries of which nine have priority: Afghanistan, Iraq, Lebanon, Mauritania, Pakistan, Palestine, Sudan, Syria, and Yemen.
The overall prevalence of HIV/AIDS in the MENA region is still low - 0.1%. However, in 2011, the increase of new infections was 35%. This places the MENA region as one of the top two regions globally with a rising HIV/AIDS epidemic, especially among the most vulnerable populations.
Between 2005 and 2015, in the MENA region, deaths linked to opportunistic infections due to HIV increased by 66%. Globally, in the same period, there was a decline of 35%.
Predominantly, this can be explained by the fact that the region has the lowest coverage in the world in terms of antiretroviral treatments (ARVs), prevention services, and other medical services: just 24%.
Barriers to accessing care services are not always clearly identified. Nevertheless, discrimination and stigma represent a significant and critical barrier in accessing treatment.
In the MENA region, according to the World Health Organization (WHO), the number of cases of people infected with TB is estimated to be a staggering one million people.
There is a lack of publications in Arabic, and sometimes French. This makes dissemination and the appropriation of Global Fund processes difficult in the many countries of the region.